Arcadia Biosciences Inc.

NASDAQ: RKDA · Real-Time Price · USD
4.41
-0.22 (-4.75%)
At close: Aug 14, 2025, 3:40 PM
4.35
-1.36%
Pre-market: Aug 15, 2025, 08:00 AM EDT

Arcadia Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
5.26M 5.31M 5.27M 5.33M 5.41M 5.67M 5.5M 5.78M 8.24M 9.96M 11.13M 11.63M 9.17M 6.78M 11.74M 9.68M 8.55M
Cost of Revenue
3.17M 3.31M 3.15M 3.23M 3.57M 3.58M 4.46M 4.7M 7.17M 9.8M 12M 13.17M 11.31M 8.71M 6.69M 6.02M 5.92M
Gross Profit
2.08M 2M 2.11M 2.1M 1.84M 2.09M 1.03M 1.07M 1.08M 155K -876K -1.54M -2.14M -1.93M 5.05M 3.66M 2.63M
Operating Income
-1.53M -5.08M -6.06M -7.54M -13.31M -14.34M -16.91M -18.23M -19.03M -19.61M -27.58M -31.74M -34.82M -35.52M -14.25M -13.12M -12.31M
Interest Income
944K 782K 585K 485K 542K 695K 704K 666K 489K 291K 125K 30K n/a n/a n/a n/a n/a
Pretax Income
-762K -5.78M -4.37M -5.67M -6.7M -8.33M -10.03M -10.42M -15.04M -15.6M -20.84M -20.8M -22.42M -16.13M 1.89M -2.43M -6.91M
Net Income
-2.02M -7.04M -5.83M -6.78M -7.02M -8.45M -9.92M -10.23M -14.83M -15.46M -20.41M -19.71M -21.19M -14.66M 3.52M -696K -5.12M
Selling & General & Admin
9.32M 10.77M 11.54M 12.74M 13.87M 15.07M 15.86M 17.26M 18.09M 18.05M 20.02M 21.5M 23.22M 22.94M 21.53M 19.51M 16.81M
Research & Development
47K 319K 638K 919K 1.3M 1.39M 1.55M 1.5M 1.47M 1.51M 1.57M 2.35M 3.13M 3.89M 5.29M 6.01M 6.88M
Other Expenses
n/a 3K 15K 32K 19K 48K 56K 39K 8K -10K -30K -37K 7K -7K -7K n/a 57K
Operating Expenses
9.36M 11.09M 12.17M 13.66M 15.17M 16.46M 17.42M 18.76M 19.57M 19.56M 21.59M 23.85M 26.34M 26.83M 26.82M 25.52M 23.69M
Interest Expense
n/a n/a n/a n/a n/a n/a 194K 194K 194K 195K 1K 16K 17K 25K 40K 48K 53K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.35M 1.35M 1.35M 581K -769K -769K -769K
Cost & Expenses
12.54M 14.4M 15.33M 16.88M 18.74M 20.04M 21.88M 23.46M 26.73M 29.36M 33.6M 37.02M 37.65M 35.54M 33.51M 31.54M 29.61M
Income Tax Expense
438K 438K 437K 7K 8K -190K -184K -183K -204K -6K -18K -18K 2K 2K -138K -130K -140K
Shares Outstanding (Basic)
1.37M 1.36M 1.36M 1.36M 1.36M 1.29M 1.36M 1.36M 864.39K 616.08K 597.29K 554.63K 554.67K 22.18M 543.75K 543.63K 474.26K
Shares Outstanding (Diluted)
1.37M 1.36M 1.36M 1.36M 1.36M 1.29M 1.36M 1.36M 864.39K 616.08K 613.81K 554.72K 554.67K 22.18M 554.43K 543.63K 476.07K
EPS (Basic)
0.32 -3.36 -4.4 -5.11 -5.29 -7.96 -12.77 -15.7 -23.11 -26.73 -20.12 -19.3 -22.17 -9.7 -8.45 -28.3 -60.17
EPS (Diluted)
0.32 -3.36 -4.4 -5.11 -5.29 -7.96 -12.77 -15.57 -22.98 -26.6 -19.99 -19.22 -22.09 -9.62 -8.37 -28.3 -60.17
EBITDA
-5.47M -8.97M -9.46M -10.88M -10.28M -11.12M -13.07M -13.81M -16.2M -17.21M -21.85M -25.13M -29.03M -29.21M -16.63M -16.37M -18.22M
EBIT
-6.06M -9.09M -10.06M -11.55M -10.99M -11.85M -13.86M -14.6M -16.94M -18.04M -22.33M -25.82M -29.71M -23.04M -10.51M -10.16M -12.38M
Depreciation & Amortization
62K 290K 491K 751K 961K 984K 1.05M 1.14M 1.29M 1.36M 1.29M 1.24M 1.12M 1.04M 1.1M 1.01M 844K